You have no items in your shopping cart.
On Promotion
Category
Tested Applications
Conjugation
Biologically Active
Featured Product
Human FGFa [orb3002326]SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 16 KDa. Observed: 16 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg- Human FGF-17 [orb3002263]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 22.64 KDa. Observed: 31 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human Thermostable FGFb [orb3002267]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 17.2 KDa. Observed: 16 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human FGF-19 [orb3002415]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 23.5 KDa. Observed: 26 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human FGF-4 [orb3002445]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 16.9 KDa. Observed: 16 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human/Mouse FGF-8b [orb3002449]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 22.5 KDa. Observed: 23 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human FGF-18 [orb3002529]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 21.9kDa. Observed: 25-37kDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Human FGFb [orb3002475]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.. SEC-HPLC: Greater than 95% as determined by SEC-HPLC. (QC verified)
Predicted: 16.3 KDa. Observed: 17 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human FGF-10 [orb3002478]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 19.5 KDa. Observed: 19-22 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human KGF [orb3002467]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 18.9 KDa. Observed: 17 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg